.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Predict branded drug patent expiration
  • Set up watchlists for daily email updates

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Daiichi Sankyo
AstraZeneca
Novartis
Fish and Richardson
Julphar
Cipla
Healthtrust
Farmers Insurance
Dow

Generated: June 24, 2017

DrugPatentWatch Database Preview

Sulfur hexafluoride lipid-type a microspheres - Generic Drug Details

« Back to Dashboard

What are the generic sources for sulfur hexafluoride lipid-type a microspheres and what is the scope of sulfur hexafluoride lipid-type a microspheres freedom to operate?

Sulfur hexafluoride lipid-type a microspheres
is the generic ingredient in one branded drug marketed by Bracco and is included in one NDA. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Sulfur hexafluoride lipid-type a microspheres has one hundred and thirty-six patent family members in twenty-eight countries.

There are two drug master file entries for sulfur hexafluoride lipid-type a microspheres. One supplier is listed for this compound.

Summary for Generic Name: sulfur hexafluoride lipid-type a microspheres

Tradenames:1
Patents:2
Applicants:1
NDAs:1
Drug Master File Entries: see list2
Suppliers / Packagers: see list1
Bulk Api Vendors: see list21
Clinical Trials: see list12,171
Patent Applications: see list8
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:sulfur hexafluoride lipid-type a microspheres at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bracco
LUMASON
sulfur hexafluoride lipid-type a microspheres
FOR SUSPENSION;INTRAVENOUS203684-001Oct 15, 2014RXYesYes► Subscribe► Subscribe
Bracco
LUMASON
sulfur hexafluoride lipid-type a microspheres
FOR SUSPENSION;INTRAVENOUS203684-001Oct 15, 2014RXYesYes► Subscribe► Subscribe
Bracco
LUMASON
sulfur hexafluoride lipid-type a microspheres
FOR SUSPENSION;INTRAVENOUS203684-001Oct 15, 2014RXYesYes5,686,060► SubscribeYY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: sulfur hexafluoride lipid-type a microspheres

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
5,445,813 Stable microbubble suspensions as enhancement agents for ultrasound echography► Subscribe
6,139,818 Method of making ultrasonic contrast agent► Subscribe
6,136,293 Stable microbubbles suspensions containing saturated lamellar phospholipids► Subscribe
6,183,725 Gas mixtures useful as ultrasound contrast media, contrast agents containing the media and method► Subscribe
5,863,520 Method of echographic imaging using polymeric gas or air filled microballoons► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: sulfur hexafluoride lipid-type a microspheres

Country Document Number Estimated Expiration
Australia2618197► Subscribe
Australia630030► Subscribe
European Patent Office0682530► Subscribe
Russian Federation2110991► Subscribe
Poland182223► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: SULFUR HEXAFLUORIDE LIPID-TYPE A MICROSPHERES

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C0004France► SubscribePRODUCT NAME: CEFTOLOZANE,EVENTUELLEMENT SOUS LA FORME D'UN SEL PHARMACEUTIQUEMENT ACCEPTABLE,PLUS PARTICULIEREMENT UN SEL D'ACIDE SULFURIQUE; REGISTRATION NO/DATE: EU/1/15/1032 20150922
C/GB01/043United Kingdom► SubscribePRODUCT NAME: SULPHUR HEXAFLUORIDE; REGISTERED: UK EU/1/01/177/001 20010326; UK EU/1/01/177/002 20010326
/2001Austria► SubscribePRODUCT NAME: SCHWEFELHEXAFLUORID ENTHALTENDE, DURCH PHOSPHORLIPID STABILISIERTE MIKROBLAESCHEN; REGISTRATION NO/DATE: EU/1/01/177/001, EU/1/01/177/002 20010326
C0036France► SubscribePRODUCT NAME: SULPHUR HEXAFLUORIDE; REGISTRATION NO/DATE: EU/1/01/177/001 20010326
00061Netherlands► SubscribePRODUCT NAME: ZWAVELHEXAFLUORIDE; REGISTRATION NO/DATE: EU/1/01/177/001-002 20010326
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Boehringer Ingelheim
Covington
Cantor Fitzgerald
Baxter
Accenture
AstraZeneca
UBS
Argus Health
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot